The Autonomic Nervous System Overview

The autonomic nervous system is the motor system for the viscera: it innervates cardiac muscle, smooth muscle in blood vessels and hollow organs, and exocrine and some endocrine glands. It is efferent — carrying commands outward from the central nervous system — but it operates alongside an extensive afferent (sensory) limb that reports on blood pressure, gut distension, blood chemistry, and organ stretch. That sensory limb feeds reflex arcs and higher integrative centers, so "autonomic nervous system" in the broad sense denotes a sensorimotor loop, even though the term itself, coined by the British physiologist John Newport Langley in the early twentieth century, emphasizes autonomy of visceral function from voluntary control. The defining structural feature is the two-neuron efferent chain. A preganglionic neuron has its cell body inside the central nervous system — in the brainstem or spinal cord — and sends a myelinated axon out to a peripheral autonomic ganglion. There it synapses on a postganglionic neuron, whose unmyelinated axon completes the journey to the target organ. This contrasts sharply with the somatic motor system, where a single lower motor neuron runs unbroken from spinal cord to skeletal muscle fiber, with no intervening peripheral synapse. The ganglionic relay is not a trivial detail; it is a site of synaptic integration, convergence, and divergence, and it is where pharmacology intervenes most cleanly (ganglionic blockers, for instance, shut down both autonomic divisions at once because both use the same relay chemistry there). The ANS is classically divided into three parts. The sympathetic division arises from thoracic and lumbar spinal segments (thoracolumbar outflow) and mediates arousal, mobilization of energy, and the classic fight-or-flight response. The parasympathetic division arises from cranial nerves and sacral spinal segments (craniosacral outflow) and mediates rest, digestion, and energy conservation. The enteric division is a semi-independent meshwork of neurons within the gut wall capable of coordinating peristalsis and secretion even when extrinsic autonomic input is severed. Most visceral organs receive dual innervation from sympathetic and parasympathetic fibers with antagonistic or complementary effects, and this push-pull arrangement, tuned continuously by central autonomic control centers, is what allows organ function to be adjusted smoothly rather than switched on and off.

Step 1 — Central command neurons. Autonomic output originates from neurons in the Hypothalamus, brainstem nuclei (particularly the nucleus tractus solitarius, dorsal motor nucleus of the vagus, nucleus ambiguus, and rostral ventrolateral medulla), and the intermediolateral cell column of the spinal cord. These central autonomic neurons do not usually project directly to organs; instead, spinal and cranial preganglionic neurons carry the final CNS-derived signal outward.

Step 2 — Preganglionic neuron and axon. Sympathetic preganglionic cell bodies sit in the intermediolateral (IML) cell column of spinal segments T1–L2/L3. Parasympathetic preganglionic cell bodies sit in brainstem nuclei associated with cranial nerves III, VII, IX, and X, and in the sacral spinal cord at S2–S4. All preganglionic axons are thin, myelinated B fibers, conducting at roughly 3–15 meters per second, and all of them release acetylcholine (ACh) at their terminal.

Step 3 — The ganglionic synapse. Preganglionic ACh acts on nicotinic acetylcholine receptors (ligand-gated cation channels) on the postganglionic neuron's cell body and dendrites within the ganglion. This produces a fast excitatory postsynaptic potential and, given sufficient summation across converging inputs, an action potential in the postganglionic neuron. Ganglia are not passive relay points: a single preganglionic axon typically diverges onto multiple postganglionic neurons (divergence ratios in sympathetic paravertebral ganglia can approach 1:20), amplifying the sympathetic signal, while parasympathetic ganglia — often embedded within or right next to the target organ — tend to show far less divergence, preserving more discrete, localized control.

Step 4 — Anatomical location of ganglia differs by division. Sympathetic ganglia lie close to the spinal cord, forming the paravertebral sympathetic chain (running the length of the vertebral column) plus prevertebral ganglia (celiac, superior and inferior mesenteric) nearer the abdominal viscera. Because these ganglia are near the cord, sympathetic preganglionic axons are short and postganglionic axons are long, traveling substantial distances to reach targets like the skin, heart, or gut. Parasympathetic ganglia, by contrast, lie near or within the target organ (e.g., the ciliary ganglion near the eye, the cardiac plexus near the heart, or intramural ganglia embedded in the gut wall), so parasympathetic preganglionic axons are long and postganglionic axons are short.

Step 5 — Postganglionic neurotransmission at the target organ. Postganglionic parasympathetic neurons release acetylcholine, acting on muscarinic acetylcholine receptors (G-protein-coupled receptors) on the target cell — slower, more modulatory signaling than the nicotinic ganglionic synapse. Postganglionic sympathetic neurons release mainly norepinephrine, acting on adrenergic receptors (α and β subtypes, also G-protein-coupled), with two conspicuous exceptions: sympathetic fibers to sweat glands release acetylcholine (acting on muscarinic receptors), and the adrenal medulla is itself a modified sympathetic ganglion whose "postganglionic" cells (chromaffin cells) have no axon at all — they are endocrine cells that release epinephrine and some norepinephrine directly into the bloodstream upon nicotinic stimulation by preganglionic fibers.

Step 6 — Organ response and receptor logic. The physiological outcome depends entirely on which receptor subtype the target cell expresses. Norepinephrine acting on β1 receptors in cardiac pacemaker cells increases heart rate; the same norepinephrine acting on α1 receptors in vascular smooth muscle causes constriction; acetylcholine acting on M2 receptors in the heart decreases rate; acetylcholine on M3 receptors in gut smooth muscle increases motility. The receptor, not the transmitter alone, determines the sign of the effect — a crucial point, because it means the same chemical messenger produces opposite outcomes in different tissues.

Step 7 — Sensory feedback and reflex closure. Visceral afferent fibers (traveling alongside both sympathetic and parasympathetic nerves, with vagal and glossopharyngeal afferents being especially important) carry information about blood pressure (baroreceptors in the carotid sinus and aortic arch), blood gases (chemoreceptors), gut distension, and cardiac filling back to the nucleus tractus solitarius in the medulla. This closes feedback loops: the baroreflex, for instance, senses a pressure rise, increases parasympathetic (vagal) output to slow the heart, and decreases sympathetic output to dilate vessels — a homeostatic circuit operating continuously and largely unconsciously.

The core claims of autonomic physiology — that a two-neuron chain relays through ganglia, that acetylcholine mediates ganglionic transmission, and that different postganglionic transmitters produce opposite effects on the same organ — rest on a body of classical experimentation spanning nearly a century.

Langley's ganglion mapping and the coining of "autonomic." John Newport Langley, working at Cambridge in the 1890s–1900s, used selective nerve stimulation, degeneration studies, and nicotine as a pharmacological tool to distinguish preganglionic from postganglionic fibers. He found that small doses of nicotine applied to a ganglion would first stimulate (mimicking preganglionic input) and then, at higher doses, block transmission through the ganglion entirely, while leaving both preganglionic axons and postganglionic cell bodies electrically excitable to direct stimulation. This showed that the ganglion contained a genuine chemical synapse — a point of transmission fundamentally different from simple axonal conduction — and that this synapse could be pharmacologically isolated. Langley used these methods systematically to trace which spinal segments supplied which ganglia and organs, building the outflow maps (thoracolumbar sympathetic, craniosacral parasympathetic) still used today, and it was Langley who introduced the term "autonomic nervous system" in 1898 to describe this self-regulating visceral motor apparatus.

Otto Loewi's "Vagusstoff" experiment (1921). Loewi's classic experiment directly demonstrated chemical transmission at the postganglionic-to-organ synapse and, indirectly, supported the whole notion of neurotransmitter-mediated autonomic action. He isolated two frog hearts, kept beating in saline-filled chambers connected by a cannula. He electrically stimulated the vagus nerve on the first heart, which slowed as expected. He then transferred the perfusion fluid bathing the first heart to the second, untouched heart. The second heart also slowed, even though its own vagus had never been stimulated. This proved that vagal stimulation released a diffusible chemical substance — which Loewi initially called "Vagusstoff" and which was later identified as acetylcholine — into the fluid, and that this substance alone was sufficient to reproduce the inhibitory effect on a distant heart. Loewi shared the 1936 Nobel Prize in Physiology or Medicine with Henry Dale for this and related work establishing chemical neurotransmission.

Henry Dale's pharmacological dissection of cholinergic transmission. Dale's work in the 1910s–1930s characterized two distinct actions of acetylcholine — a "muscarinic" action, mimicked by the mushroom alkaloid muscarine and blocked by atropine, seen at postganglionic parasympathetic synapses and sweat glands, and a "nicotinic" action, mimicked by nicotine, seen at the ganglionic synapse and the neuromuscular junction. This pharmacological distinction — still the basis of receptor nomenclature today — was essential evidence that the ganglionic synapse (nicotinic) and the postganglionic-to-organ synapse (muscarinic, in the parasympathetic case) are pharmacologically separable sites, exactly as required by a genuine two-neuron relay with two different receptor populations in series.

Ulf von Euler's identification of norepinephrine as the sympathetic transmitter (1946). Von Euler used chromatography and bioassay techniques to show that extracts of sympathetic nerve tissue and stimulated organs contained predominantly norepinephrine rather than epinephrine, correcting the earlier assumption (based on adrenal medulla studies) that sympathetic nerves released epinephrine. This established the transmitter asymmetry central to the ANS: parasympathetic postganglionic neurons are cholinergic, sympathetic postganglionic neurons are (with exceptions) noradrenergic. Von Euler shared the 1970 Nobel Prize in Physiology or Medicine with Loewi's intellectual heirs Julius Axelrod and Bernard Katz for work elucidating neurotransmitter storage, release, and inactivation. Together, these experiments — ganglionic pharmacology, cross-perfusion transmission, muscarinic/nicotinic pharmacological separation, and transmitter identification by chromatography — converted the anatomical picture of preganglionic and postganglionic fibers into a fully mechanistic account of how a chemical signal crosses two synapses in series to control an internal organ.

Example 1 — Tracing a real reflex arc: the baroreflex response to standing up. When a person stands, roughly 500–800 mL of blood pools in the legs due to gravity, and venous return to the heart drops. Mean arterial pressure falls transiently, typically by 5–10 mmHg in a healthy young adult. Work through the circuit: 1. Baroreceptors in the carotid sinus and aortic arch, which normally fire tonically in proportion to arterial stretch, register decreased firing. 2. Afferent fibers (via the glossopharyngeal and vagus nerves) carry this reduced signal to the nucleus tractus solitarius (NTS) in the medulla. 3. The NTS, normally exciting the vagal cardioinhibitory neurons (nucleus ambiguus/dorsal motor nucleus) and inhibiting the rostral ventrolateral medulla (RVLM, the sympathetic premotor center), now does the opposite: reduced baroreceptor input disinhibits the RVLM and reduces vagal drive. 4. Sympathetic preganglionic neurons in the spinal IML increase firing; postganglionic norepinephrine release increases heart rate (β1 receptors) and constricts vessels (α1 receptors); parasympathetic (vagal) tone on the heart decreases. 5. Net effect: heart rate rises by roughly 10–20 beats per minute and peripheral resistance increases, restoring blood pressure within about 10–15 seconds. This is precisely why patients with autonomic failure (e.g., from diabetic autonomic neuropathy or Parkinson-associated synucleinopathies) experience orthostatic hypotension — dizziness or fainting on standing — because steps 3–4 fail even though the heart and vessels themselves are structurally normal. The defect is in the reflex arc's central and ganglionic relay, not in the end organ.

Example 2 — Pharmacological reasoning: predicting the effect of a ganglionic blocker versus a muscarinic blocker. A drug that blocks nicotinic receptors at autonomic ganglia (a ganglionic blocker, e.g., historically used agents like trimethaphan) will interrupt transmission at the first synapse of both sympathetic and parasympathetic chains simultaneously, because both divisions use nicotinic ACh receptors at the ganglion. Predict the effect on heart rate: at rest, the heart is under dominant parasympathetic (vagal) tone, so blocking both outflows removes the larger (vagal) brake along with the smaller sympathetic drive, and the net observed effect is typically a rise in resting heart rate (unmasking the sympathetic-favoring shift because vagal tone was stronger to begin with) alongside a fall in blood pressure (loss of sympathetic vasoconstrictor tone dominates in the vasculature, since vessels receive little or no parasympathetic innervation). Now contrast with atropine, a muscarinic receptor antagonist. Atropine acts only at the second synapse of the parasympathetic chain (postganglionic-to-organ) and at sympathetic cholinergic synapses onto sweat glands; it does not touch ganglionic nicotinic transmission or sympathetic noradrenergic synapses. Predict the effect: atropine selectively removes parasympathetic (vagal) restraint on the heart, producing tachycardia, dries secretions (dry mouth, reduced sweating), and dilates the pupil (blocking the sphincter pupillae's muscarinic receptors), while leaving sympathetically-mediated vasoconstriction and adrenal catecholamine release entirely intact. The difference between these two drugs — one hitting the shared ganglionic step, one hitting a division-specific postganglionic step — is a direct pharmacological readout of the two-neuron, two-synapse architecture described above.

John Newport Langley trained and then spent his entire career at Cambridge, eventually becoming Chair of Physiology and, for over three decades, editor of the Journal of Physiology, a position from which he shaped the direction of British physiology broadly. His early research concerned the secretory glands and the effects of drugs like pilocarpine and atropine on salivary secretion, work that drew him toward the puzzle of how the nervous system controlled glandular and visceral function at all. Langley's decisive methodological contribution was his systematic use of nicotine as a chemical scalpel. By applying nicotine locally to autonomic ganglia, he could selectively block transmission through the ganglionic synapse while leaving the preganglionic axon and the postganglionic cell body separately excitable by direct electrical stimulation — proving that the ganglion was the site of a distinct, pharmacologically vulnerable synaptic step, not merely a structural way-station. He extended this technique across the sympathetic chain and cranial and sacral parasympathetic outflows, painstakingly mapping which spinal or cranial segments innervated which ganglia and which ganglia in turn innervated which organs — the outflow scheme (thoracolumbar sympathetic, craniosacral parasympathetic) that remains the organizing anatomical framework of the field. In 1898 Langley proposed the term "autonomic nervous system" for this self-regulating visceral efferent apparatus, deliberately choosing a name that emphasized its independence from direct voluntary control, and in later work (1921's The Autonomic Nervous System, Part I) he formalized the tripartite division into sympathetic, parasympathetic, and enteric systems still taught today. His student Walter Gaskell had earlier identified the thoracolumbar and craniosacral outflow pattern anatomically; Langley's pharmacological experiments supplied the functional proof that these outflows constituted genuinely distinct, synaptically organized systems.

Autonomic physiology is not a museum piece of classical experiments; it is the daily working substrate of enormous swaths of clinical medicine. Anesthesiology relies constantly on autonomic pharmacology: atropine or glycopyrrolate is given to block excessive vagal bradycardia during surgery, and ganglionic and adrenergic agents are used to control blood pressure during procedures. Cardiology treats hypertension and heart failure with beta-blockers that dampen sympathetic β1 drive on the heart, and manages neurocardiogenic syncope by targeting exaggerated vagal reflexes. Endocrinology and diabetes care confronts autonomic neuropathy as one of the most disabling complications of long-standing diabetes, producing orthostatic hypotension, gastroparesis (delayed gastric emptying from vagal damage), and silent myocardial ischemia because cardiac pain afferents are also autonomic fibers.

Neurology uses autonomic testing — heart rate variability, tilt-table testing, sweat testing — to diagnose disorders like multiple system atrophy, pure autonomic failure, and Parkinson's disease, all of which involve degeneration of central or peripheral autonomic neurons well before or alongside classical motor symptoms. Ophthalmology and pharmacology exploit muscarinic receptor pharmacology directly: pilocarpine (a muscarinic agonist) and atropine-family antagonists are used routinely to constrict or dilate the pupil for diagnosis and treatment of glaucoma. Emergency medicine and toxicology deal with organophosphate poisoning (pesticides, nerve agents), which blocks acetylcholinesterase and causes catastrophic overactivation of muscarinic synapses throughout the body — treated precisely with atropine, a direct pharmacological antagonist at the receptor this article describes. Gastroenterology manages irritable bowel syndrome, gastroparesis, and neurogenic bowel by targeting both extrinsic autonomic input and the Enteric Nervous System's intrinsic circuitry. Even psychiatry increasingly measures autonomic markers (heart rate variability, skin conductance) as biomarkers of anxiety and stress-system dysregulation, tying the two-neuron chain described here directly to disorders of mood and arousal.

Ask the tutor: How exactly does the baroreflex arc differ in speed and pathway from the slower hormonal (renin-angiotensin) mechanism for blood pressure control?